Status:
UNKNOWN
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
HanAll BioPharma Co., Ltd.
Conditions:
Sarcopenia
Prostate Cancer
Eligibility:
MALE
20+ years
Brief Summary
This study aimed to evaluate the correlation of change in body composition and oncological outcomes of prostate cancer patients under androgen deprivation therapy(ADT).
Detailed Description
Sarcopenia, decrease lean body mass (LBM) is the well-known parameter which negatively related to physical activity, morbidity and patients survival. Aging and decreased blood androgen level are well ...
Eligibility Criteria
Inclusion
- Age over 20 year-old
- Patient with ECOG-PS 0 to 2
- Prostate cancer patients
- Considered Androgen deprivation therapy with any cause
- Patient agreed with informed consent of this study
Exclusion
- History of previous ADT
- Planned intermittent treatment or short term ADT (less than 2 year)
- Contraindication of ADT
- Severe cognitive impairment, who cannot eligible for survey
- Secondary malignancy
- Patient cannot perform InBody test because of physical or underlying disease.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04037488
Start Date
August 1 2019
End Date
October 30 2021
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744